Skip to content
akaturk Academic measurement
Search
2025 SJR Q2 JCR Q4 · 0,7 340 matched articles SCIE

Journal detail

Vascular

Publisher
SAGE Publications Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 17085381
  • 1708539X
Scopus 0,393 SJR
Scopus Q2 SJR Q
WoS Q4 JCR Q
WoS 0,7 JIF
Scopus 62 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,393
  • Quartile Q2
  • H-Index 62
  • Cites/doc 0,99
  • Docs (3y) 539
  • Cites (3y) 629

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,7
  • 5Y JIF 1
  • JCI 0,2

WoS indexes

  • SCIE

Subject classification

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q4 0,393 0,7 1 0,2 Q4 62
2024 Q2 Q4 0,488 0,9 1,1 0,23 Q4 61
2023 Q2 Q4 0,415 1 1,1 0,23 Q4 61
2022 Q2 Q4 0,433 1,1 1,2 0,21 Q4 61
2021 Q3 Q4 0,385 1,1 1,3 0,21 Q4 61
2020 Q2 Q4 0,535 1,3 1,3 0,3 Q4 61
2019 Q2 Q4 0,571 1,3 1,1 0,32 Q4 61
2018 — Q4 — 1,2 0,9 0,28 Q4 —
2017 Q2 Q4 0,477 1,1 0,9 0,24 Q4 61
2016 Q3 Q4 0,36 0,7 0,7 — — 61
2015 Q3 Q4 0,366 0,6 0,7 — — 61
2014 Q3 Q4 0,372 0,8 0,8 — — 61
2013 Q2 Q4 0,522 1 0,9 — — 61
2012 Q2 Q4 0,435 0,9 0,9 — — 61
2011 Q2 Q4 0,501 0,9 1 — — 61
2010 Q2 Q4 0,466 0,6 1 — — 61
2009 — Q4 — 0,9 — — — —
2008 — Q4 — 0,9 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 89/100
2024 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 86/98
2023 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 81/96
2022 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 66/68
2021 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 65/67
2020 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 62/65
2019 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 58/65
2018 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 60/65
2017 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 64/65
2016 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 63/63
2015 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 63/63
2014 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 59/60
2013 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 60/65
2012 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 60/68
2011 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 60/68
2010 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 61/68
2009 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 52/61
2008 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 51/56